| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVRI | Common Stock | Options Exercise | $250K | +38K | +17.98% | $6.59 | 249K | Jul 1, 2021 | Direct | F1 |
| transaction | EVRI | Common Stock | Sale | -$971K | -38K | -15.24% | $25.56 | 211K | Jul 1, 2021 | Direct | F1, F2 |
| transaction | EVRI | Common Stock | Options Exercise | $84.1K | +11.9K | +5.61% | $7.09 | 223K | Jul 1, 2021 | Direct | F3 |
| transaction | EVRI | Common Stock | Sale | -$303K | -11.9K | -5.31% | $25.56 | 211K | Jul 1, 2021 | Direct | F3, F4 |
| transaction | EVRI | Common Stock | Options Exercise | $0 | +695 | +0.33% | $0.00 | 212K | Jul 1, 2021 | Direct | F5 |
| transaction | EVRI | Common Stock | Tax liability | -$7.02K | -273 | -0.13% | $25.73 | 212K | Jul 1, 2021 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVRI | Stock Option | Options Exercise | $0 | -38K | -38.78% | $0.00 | 60K | Jul 1, 2021 | Common Stock | 38K | $6.59 | Direct | F7 |
| transaction | EVRI | Stock Option | Options Exercise | $0 | -11.9K | -100% | $0.00* | 0 | Jul 1, 2021 | Common Stock | 11.9K | $7.09 | Direct | F8 |
| transaction | EVRI | Restricted Stock Units | Options Exercise | $0 | -695 | -4.55% | $0.00 | 14.6K | Jul 1, 2021 | Common Stock | 695 | Direct | F5, F9 |
| Id | Content |
|---|---|
| F1 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on May 21, 2021 for options originally granted on May 2, 2014. |
| F2 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $25.00 to $25.83. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on May 21, 2021 for options originally granted on March 6, 2013. |
| F4 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $25.09 to $25.83. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of common stock. |
| F6 | Represents the withholding by the Company of shares of common stock, acquired upon the vesting of restricted stock units, to satisfy the statutory tax obligation applicable to such transactions with the withheld shares being included in treasury stock. |
| F7 | Represents an option to purchase 100,000 shares of the Company's common stock, which vested in equal annual installments over a period of four years following the date of grant. |
| F8 | Represents an option to purchase 15,811 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant. |
| F9 | Represents restricted stock units to acquire shares of the Company's common stock that vest in equal monthly installments over a period of three years following the date of grant of April 1, 2020. |